BIOMAT Database Logo BIOMAT Database Logo

Expression of cdc25A and cdc25B proteins in thyroid neoplasms. 2002

Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Department of Surgery, Kuma Hospital, 8-2-35, Shimoyamate-dori, Chuo-ku, Kobe City 650-0011, Japan. ito01@kuma-h.or.jp

Cdc25B and cdc25A phosphates are prominent stimulators of cell cycle progression and recent studies have also suggested their oncogenic roles. To elucidate the role of these proteins in thyroid neoplasms, we immunohistochemically investigated their expression, and neither protein was expressed in normal follicular cells. Cdc25B was frequently overexpressed in follicular adenoma and minimally invasive follicular carcinoma, but the incidence was significantly lower in widely invasive follicular carcinoma. Furthermore, the cdc25B expression level significantly decreased with the dedifferentiation of thyroid carcinoma. Cdc25A overexpression was observed in high incidences in all types of thyroid neoplasms. These results suggest that cdc25B and cdc25A play oncogenic roles in thyroid follicules and that cdc25B works predominantly in the early phase of the progression of thyroid carcinoma, whereas cdc25A plays a fundamental role in the development of thyroid neoplasms.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
April 2015, The British journal of ophthalmology,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Chromosome mapping of human CDC25A and CDC25B phosphatases.
October 1993, Genomics,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
August 2001, British journal of cancer,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Overexpression of CDC25A and CDC25B in head and neck cancers.
June 1997, Cancer research,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.
May 2014, Oncogene,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.
July 2012, Bioorganic & medicinal chemistry,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B.
December 2010, The Journal of biological chemistry,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
May 2005, Proceedings of the National Academy of Sciences of the United States of America,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Retinoblastoma expression in thyroid neoplasms.
May 2000, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Y Ito, and H Yoshida, and K Nakano, and K Kobayashi, and T Yokozawa, and K Hirai, and F Matsuzuka, and N Matsuura, and K Kakudo, and K Kuma, and A Miyauchi
Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.
October 2005, Thyroid : official journal of the American Thyroid Association,
Copied contents to your clipboard!